Inmunomet Overview
- Year Founded
-
2018
- Status
-
Private
Inmunomet General Information
Description
Operator of a chain of hospitals intended to treat chronic pathologies linked to food intolerances and intestinal dysbiosis. The company specializes in intolerances and gut dysbiosis-related disorders including digestive medical surgical such as endoscopies and functional tests, clinical laboratory, diagnostic imaging, rheumatology, pulmonology, ENT, and more.
Contact Information
Website
www.inmunomet.comCorporate Office
- Calle De Montesa, 17
- Community of Madrid
- 28006 Madrid
- Spain
Corporate Office
- Calle De Montesa, 17
- Community of Madrid
- 28006 Madrid
- Spain
Inmunomet Investments (1)
Inmunomet’s most recent deal was a Later Stage VC with MicroViable Therapeutics for . The deal was made on 21-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MicroViable Therapeutics | 21-Apr-2022 | Later Stage VC | Drug Discovery |
Inmunomet FAQs
-
When was Inmunomet founded?
Inmunomet was founded in 2018.
-
Where is Inmunomet headquartered?
Inmunomet is headquartered in Madrid, Spain.
-
What industry is Inmunomet in?
Inmunomet’s primary industry is Hospitals/Inpatient Services.
-
Is Inmunomet a private or public company?
Inmunomet is a Private company.
-
What is Inmunomet’s current revenue?
The current revenue for Inmunomet is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process